Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-09-16 00:00:00 ET · period of report 2022-09-14 · accession 0001567619-22-017560 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-16 | 2022-09-14 | TXG | Kosaraju Sridhar | Dir | M - OptEx | $11.48 | +10.0K | 30.6K | +49% | +$114.8K |
| D | 2022-09-16 | 2022-09-14 | TXG | Kosaraju Sridhar | Dir | M - OptEx | $0.00 | -10.0K | 84.2K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-09-14 | M | A | 10,000 | $11.48 | 30,578 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2022-09-14 | M | D | 10,000 | $0.00 | 84,167 | D | $11.48 · — to 2029-05-10 | 10,000 Class A Common Stock | (F2) This option, originally for 130,000 shares, of which 45,833 have been exercised, vested as to one forty-eighth of the shares on April 29, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. This option may be exercised prior to vesting, subject to the Issuer's right to repurchase unvested shares. |